Technical Analysis for AQS - Aequus Pharmaceuticals Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Fell Below 20 DMA | Bearish | 100.00% | |
| New 52 Week Closing Low | Bearish | 100.00% | |
| Narrow Range Bar | Range Contraction | 100.00% | |
| Wide Bands | Range Expansion | 100.00% | |
| Below Lower BB | Weakness | 100.00% |
| Alert | Time |
|---|---|
| Down 2 ATRs | 5 days ago |
| Down 1 ATR | 5 days ago |
| Down 5% | 5 days ago |
| Down 3% | 5 days ago |
| Down 2% | 5 days ago |
Get a Trading Assistant
- Earnings date: 2024-11-27
Aequus Pharmaceuticals Inc. Description
Aequus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products. The Company operates through the segment of sales and marketing of pharmaceutical drugs developed by the Company or by its collaborative partners. Its products include tacrolimus immediate releaser, which is an immunosuppressive therapy used for the treatment and prevention of acute rejection following organ transplantation; Vistitan, which is a ophthalmology product; Topiramate extended-release (XR), which is a once-daily topiramate product designed for patient compliance, and Oxcarbazepine XR, which is a once-daily oxcarbazepine product. Its development-stage pipeline includes various products in neurology and psychiatry. Its lead development-stage product candidate is AQS-1301. In addition, the Company is developing a pipeline of other central nervous system product candidates. It has over two preclinical-stage programs and a clinical-stage program in development.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Chemistry Marketing Media Medicine Pipe Pharma Pipeline Pharmaceutical Clinic Labor Drug Drugs Pharmaceuticals Titan Therapy Ophthalmology Plantation Neurology Pharmaceutical Drugs Various Product Anticonvulsants Central Nervous System Nervous System Transplantation Xr
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.06 |
| 52 Week Low | 0.005 |
| Average Volume | 120,438 |
| 200-Day Moving Average | 0.028 |
| 50-Day Moving Average | 0.018 |
| 20-Day Moving Average | 0.011 |
| 10-Day Moving Average | 0.011 |
| Average True Range | 0.003 |
| RSI (14) | 46.52 |
| ADX | 10.74 |
| +DI | 32.573 |
| -DI | 26.556 |
| Chandelier Exit (Long, 3 ATRs) | 0.005 |
| Chandelier Exit (Short, 3 ATRs) | 0.015 |
| Upper Bollinger Bands | 0.017 |
| Lower Bollinger Band | 0.006 |
| Percent B (%b) | 0.37 |
| BandWidth | 94.737 |
| MACD Line | -0.002 |
| MACD Signal Line | -0.002 |
| MACD Histogram | 0.0003 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.010 | ||||
| Resistance 3 (R3) | 0.010 | 0.010 | 0.010 | ||
| Resistance 2 (R2) | 0.010 | 0.010 | 0.010 | 0.010 | |
| Resistance 1 (R1) | 0.010 | 0.010 | 0.010 | 0.010 | 0.010 |
| Pivot Point | 0.010 | 0.010 | 0.010 | 0.010 | 0.010 |
| Support 1 (S1) | 0.010 | 0.010 | 0.010 | 0.010 | 0.010 |
| Support 2 (S2) | 0.010 | 0.010 | 0.010 | 0.010 | |
| Support 3 (S3) | 0.010 | 0.010 | 0.010 | ||
| Support 4 (S4) | 0.010 |
